Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury following Intestinal Ischemia Reperfusion Injury in Mice

<div>Experimental protocols. Mice were subjected to 45 min of SMA occlusion followed by 2 h of reperfusion. II/R: intestinal ischemia/reperfusion, NS: normal saline, Rb1: ginsenoside Rb1, and ATRA: all-transretinoic acid.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury following Intestinal Ischemia Reperfusion Injury in Mice 

Figure 1 | Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury following Intestinal Ischemia Reperfusion Injury in Mice 